Canntab Therapeutics Limited
CTABF · OTC
2/28/2023 | 11/30/2022 | 8/31/2022 | 5/31/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $17 | $55 | $145 | $691 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $3 | $20 | $44 | $210 |
| Inventory | $287 | $481 | $573 | $489 |
| Other Curr. Assets | $30 | $0 | $211 | $0 |
| Total Curr. Assets | $336 | $584 | $1,031 | $1,465 |
| Property Plant & Equip (Net) | $342 | $766 | $925 | $1,084 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $276 | $290 | $291 | $304 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | -$1,057 | -$1,216 | $0 |
| Total NC Assets | $618 | $1,057 | $1,216 | $1,387 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $954 | $1,641 | $2,247 | $2,852 |
| Liabilities | – | – | – | – |
| Payables | $204 | $188 | $126 | $161 |
| Short-Term Debt | $1,896 | $1,589 | $1,468 | $1,360 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $884 | $866 | $129 |
| Other Curr. Liab. | $167 | $228 | $154 | $77 |
| Total Curr. Liab. | $3,113 | $2,841 | $2,605 | $2,558 |
| LT Debt | $0 | $193 | $152 | $126 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $201 | $45 | $278 |
| Total NC Liab. | $0 | $547 | $374 | $606 |
| Other Liabilities | -$0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $255 | $305 | $354 |
| Total Liabilities | $3,113 | $3,388 | $2,979 | $3,163 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $13,443 | $13,443 | $13,443 | $13,443 |
| Retained Earnings | -$18,611 | -$18,198 | -$17,167 | -$16,699 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | -$2,160 | -$1,747 | -$733 | -$311 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $954 | $1,641 | $2,247 | $2,852 |
| Net Debt | $1,879 | $1,727 | $1,475 | $795 |